
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+2
Apogenix develops innovative immunotherapeutics for the treatment of cancer and viral infections, such as COVID-19. The company has built a promising pipeline of drug candidates that target different TNFSF-dependent signaling pathways, thereby reducing lymphopenia and inflammatory cell death in patients with viral infections and restoring the anti-tumor immune response in cancer patients
Development of immunotherapeutics,tnf superfamily signaling,drug candidates for cancer treatment,cd95,glioblastoma,myelodysplastic syndromes,and covid-19
Apogenix gmbh operates in the Biotechnology research industry.
Apogenix gmbh's revenue is 11m - 100m
Apogenix gmbh has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.